Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.85% | $1.03B | €343.40B | 29.52% | 76 Outperform | |
| AstraZeneca | 1.90% | $688.04M | £211.99B | 30.73% | 80 Outperform | |
| Roche Holding AG | 1.84% | $664.29M | CHF263.28B | 43.76% | 73 Outperform | |
| Nestlé SA | 1.72% | $622.97M | CHF196.70B | 17.89% | 71 Outperform | |
| SAP SE | 1.70% | $614.44M | €242.41B | -12.99% | 66 Neutral | |
| HSBC Holdings | 1.69% | $610.08M | HK$2.12T | 51.25% | 80 Outperform | |
| Novartis AG | 1.67% | $603.21M | CHF209.54B | 23.96% | 80 Outperform | |
| Shell (UK) | 1.48% | $535.17M | £153.76B | 10.55% | 73 Outperform | |
| Siemens | 1.33% | $482.09M | €186.24B | 25.32% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.29% | $466.70M | €314.21B | 0.08% | 78 Outperform |